Sangamo Therapeutics Gains FDA Approval for ST-503...
Category : Approval/Launch 21 November 2024Overview Sangamo Therapeutics has received clearance from the U.S. Food and Drug Administration (...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
TAHO Pharma Begins Patient Dosing in US Phase III...
Category : Clinical Trial Update 21 November 2024Overview TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its US phase III...
Anixa Biosciences Begins Patient Dosing in Phase 1...
Category : Clinical Trial Update 21 November 2024Anixa Biosciences begins patient dosing in third cohort in ongoing phase 1 trial of novel CAR-T ther...
Merck’s Phase 3 Trial of Subcutaneous Pembrolizuma...
Category : Clinical Trial Update 21 November 2024Merck’s phase 3 trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary...
Foresee Pharma Gets Positive Recommendation From D...
Category : Clinical Trial Update 20 November 2024Foresee Pharma gets positive recommendation from DSMB to continue Casppian phase 3 study of leuproli...
Latest Newsletter Post
-
Sangamo Therapeutics Gains FDA Appr..
21 November 2024
-
TAHO Pharma Begins Patient Dosing i..
21 November 2024
-
Anixa Biosciences Begins Patient Do..
21 November 2024
-
Merck’s Phase 3 Trial of Subcutaneo..
21 November 2024
-
Foresee Pharma Gets Positive Recomm..
20 November 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com